Search research articles
Contact Us
Filters
Showing results (121-130 of 185) with videos related to
Page
of 19
Sort By:
The Journal of Antimicrobial Chemotherapy
|
January 1, 1997
Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993
F Espinasse, R Gheorghiu, A Poiata, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
Obtainment of SHV-2 beta-lactamase overproducing mutants from Escherichia coli and Klebsiella pneumoniae clinical isolates
H Ben Yaghlane, S Ben Redjeb, A Boujenah, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae
D Sirot, C Chanal, R Labia, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital
C Chanal, R Bonnet, C De Champs, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca
D Sirot, R Labia, P Pouedras, et al.
Biochimica Et Biophysica Acta
|
March 21, 1998
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling
E B Chaibi, J Péduzzi, S Farzaneh, et al.
Annales De Microbiologie
|
November 1, 1976
[Constitutive cephalosporinases from "Escherichia coli" (author's transl)]
R Labia, G Brunet, M Guionie, et al.
Journal of Biological Standardization
|
April 1, 1986
[Study of phages used in lysotyping of Listeria monocytogenes and proposal of classification by multidimensional treatment]
A Audurier, S Ortel, F Benoist, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1988
Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins
R Labia, A Morand, K Tiwari, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases
M M Caniça, M Barthélémy, L Gilly, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 185) with videos related to
Sort By:
Page
of 19
The Journal of Antimicrobial Chemotherapy
|
January 1, 1997
Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993
F Espinasse, R Gheorghiu, A Poiata, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
Obtainment of SHV-2 beta-lactamase overproducing mutants from Escherichia coli and Klebsiella pneumoniae clinical isolates
H Ben Yaghlane, S Ben Redjeb, A Boujenah, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae
D Sirot, C Chanal, R Labia, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital
C Chanal, R Bonnet, C De Champs, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca
D Sirot, R Labia, P Pouedras, et al.
Biochimica Et Biophysica Acta
|
March 21, 1998
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling
E B Chaibi, J Péduzzi, S Farzaneh, et al.
Annales De Microbiologie
|
November 1, 1976
[Constitutive cephalosporinases from "Escherichia coli" (author's transl)]
R Labia, G Brunet, M Guionie, et al.
Journal of Biological Standardization
|
April 1, 1986
[Study of phages used in lysotyping of Listeria monocytogenes and proposal of classification by multidimensional treatment]
A Audurier, S Ortel, F Benoist, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1988
Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins
R Labia, A Morand, K Tiwari, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases
M M Caniça, M Barthélémy, L Gilly, et al.
Page
of 19